Cited by 70

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Apolipoprotein E enhances uptake of soluble but not aggregated amyloid‐β protein into synaptic terminals

Gylys, Karen H., Fein, Jeffrey A., Tan, Aiko M., Cole, Gregory M.·2003·Journal of Neurochemistry

Abstract

The cellular mechanism by which apolipoprotein E (apoE) affects the pathogenesis of Alzheimer's disease (AD) is not understood. We have examined the effect of apolipoprotein E on the internalization of exogenous amyloid‐β 1–40 (Aβ40) into a rat brain crude synaptosomal preparation. Aβ40 peptide in soluble (within 1 h of dilution in buffer) or aggregated (aged 4 days before dilution in buffer) form was pre‐incubated with lipidated apoE then added to synaptosomes; intraterminal amyloid‐β labeling was quantified using flow cytometry following immunolabeling with the anti‐Aβ (10G4) antibody. The number of Aβ‐positive synaptosomes was increased (∼50%) by treatment with a soluble Aβ/apoE mixture compared with treatment with soluble Aβ40 alone. However, when the Aβ was aggregated, less sodium dodecyl sulfate (SDS)‐stable Aβ/apoE complex was formed and the addition of apoE decreased the number of Aβ‐positive terminals. The addition of the lipoprotein‐receptor related protein (LRP) antagonist receptor‐associated protein (RAP) inhibited the apoE‐induced increase in synaptosomal Aβ, and controls treated with trypsin and heparinase confirm intraterminal localization of the majority of the soluble Aβ. The apoE‐mediated increase in Aβ labeling was confirmed in intact cells by immunocytochemistry of dorsal root ganglion (DRG) neurons. These results suggest that complex formation with apoE enhances internalization of soluble Aβ uptake into terminals.

Overview

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2003.01643.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 45

  1. 10.1073/pnas.96.26.15233 · DOI · Paper page
  2. 10.1046/j.1471-4159.1998.70041458.x · DOI · Paper page
  3. 10.1016/S0006-8993(96)01262-0 · DOI · Paper page
  4. 10.1021/bi952852v · DOI
  5. 10.1038/6374 · DOI · Paper page
  6. 10.1126/science.8346443 · DOI · Paper page
  7. 10.1016/0006-8993(86)91464-2 · DOI
  8. Funato H., 1998, Quantitation of amyloid beta‐protein (A beta) in the cortex during aging and in Alzheimer's disease, Am. J. Pathol., 152, 1633
  9. Gliemann J., 1998, Receptors of the low density lipoprotein (LDL) receptor family in Man. Multiple functions of the large family members via interaction with complex ligands, Biol. Chem., 379, 951
  10. 10.1074/jbc.271.18.10602 · DOI
  11. 10.1002/1097-4547(20000715)61:2<186::AID-JNR9>3.0.CO;2-X · DOI
  12. 10.1023/A:1019840417796 · DOI
  13. 10.1016/S0021-9258(18)54845-6 · DOI · Paper page
  14. 10.1016/0076-6879(86)29091-6 · DOI · Paper page
  15. 10.1016/S0006-8993(96)01363-7 · DOI · Paper page
  16. 10.1074/jbc.272.50.31285 · DOI · Paper page
  17. 10.1016/S0166-2236(00)01749-5 · DOI · Paper page
  18. 10.1073/pnas.89.16.7437 · DOI · Paper page
  19. 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H · DOI
  20. 10.1073/pnas.95.11.6448 · DOI · Paper page
  21. 10.1073/pnas.91.25.12243 · DOI · Paper page
  22. 10.1016/S0002-9440(10)65184-X · DOI · Paper page
  23. 10.1159/000111351 · DOI
  24. 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · DOI
  25. 10.1523/JNEUROSCI.21-18-07226.2001 · DOI
  26. 10.1523/JNEUROSCI.20-11-04050.2000 · DOI · Paper page
  27. 10.1111/j.1471-4159.1984.tb12851.x · DOI
  28. 10.1016/S0896-6273(00)80187-7 · DOI · Paper page
  29. 10.1016/0922-4106(91)90014-9 · DOI
  30. 10.1016/0006-8993(91)91553-D · DOI
  31. 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
  32. 10.1002/ana.410370212 · DOI · Paper page
  33. 10.1073/pnas.90.22.10836 · DOI · Paper page
  34. 10.1073/pnas.95.26.15598 · DOI
  35. 10.1002/cyto.990120312 · DOI
  36. 10.1038/399a023 · DOI · Paper page
  37. 10.1073/pnas.90.5.1977 · DOI · Paper page
  38. Strittmatter W. J., 1993, Binding of human apolipoprotein E to synthetic amyloid‐β peptide: isoform‐specific effects and implications for late‐onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 8098, 10.1073/pnas.90.17.8098 · DOI · Paper page
  39. Terry R. D., 1999, Alzheimer Disease, 187
  40. 10.1111/j.1471-4159.1978.tb00112.x · DOI
  41. 10.1006/bbrc.1993.1423 · DOI · Paper page
  42. Wisniewski T., 1994, Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145, 1030
  43. 10.1523/JNEUROSCI.09-01-00094.1989 · DOI
  44. 10.1016/S0306-4522(98)00561-2 · DOI · Paper page
  45. 10.1097/00001756-199410270-00032 · DOI

Cited by

Sorted by citations

Metadata

Authors
Gylys, K. H., Fein, J. A., Tan, A. M., & Cole, G. M.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2003-02-28
Volume
84
Issue
6
Pages
1442-1451
ISSN
  • 0022-3042
  • 1471-4159
Cited by
70
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review